+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study



Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study



Journal of Infection 56(5): 319-325



The aim of this study was to determine risk factors for relapse of ventilator-associated pneumonia (VAP) related to nonfermenting Gram negative bacilli (NF-GNB). This is a retrospective case-control study based on prospectively collected data. Two hundred and seventy six patients with monobacterial VAP related to NF-GNB were eligible. Patients with subsequent superinfection or persistent pulmonary infection were excluded. Patients with relapse of NF-GNB VAP were matched (1:2) with patients without relapse. Matching criteria included the duration of mechanical ventilation before VAP relapse, age+/-5 years, SAPS II at ICU admission+/-5, and the date of admission. Univariate and multivariate analyses were used to determine risk factors for relapse of NF-GNB VAP in cases and controls. Thirty (10%) patients developed a relapse of NF-GNB VAP, 27 (90%) patients were successfully matched with 54 controls. Inappropriate initial antibiotic treatment was the only variable independently associated with relapse of VAP related to NF-GNB (OR [95% CI]=8.1 [2-33], p=0.003). Although ICU-mortality rate was similar in cases and controls (55% vs 72%, p=0.132), the duration of mechanical ventilation and ICU stay were significantly higher in cases than in controls. Inappropriate initial antibiotic treatment is independently associated with relapse of VAP related to NF-GNB.

(PDF emailed within 0-6 h: $19.90)

Accession: 055582902

Download citation: RISBibTeXText

PMID: 18405975

DOI: 10.1016/j.jinf.2008.02.012


Related references

Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli. Annals of Translational Medicine 6(21): 424-424, 2018

Ability of the MicroScan rapid gram-negative ID type 3 panel to identify nonenteric glucose-fermenting and nonfermenting gram-negative bacilli. Journal of Clinical Microbiology 40(10): 3750-3752, 2002

Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli. Respirology 14(1): 105-111, 2008

Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infection Control and Hospital Epidemiology 18(12): 809-813, 1998

Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia. International Journal of Antimicrobial Agents 40(5): 434-439, 2013

Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients. Clinical Transplantation 24(6): 758-765, 2011

Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli. European Journal of Clinical Microbiology and Infectious Diseases 27(8): 657-661, 2008

Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli. Surgical Infections 8(6): 589-597, 2008

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Annals of PharmacoTherapy 40(2): 219-223, 2006

Community-acquired pneumonia and Gram-negative bacilli in Cambodia-incidence, risk factors and clinical characteristics. Transactions of the Royal Society of Tropical Medicine and Hygiene 112(2): 57-63, 2018

Clinical investigation and risk factors analysis on nosocomical pneumonia caused by non-fermentation gram-negative bacilli. Journal of China Medical University 34(2): 167-168, 2005

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia. Journal of Antimicrobial ChemoTherapy 70(5): 1487-1494, 2015

Ventilator-associated pneumonia and upper airway colonisation with Gram negative bacilli: the role of stress ulcer prophylaxis in children. Intensive Care Medicine 28(6): 763-767, 2002

Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study. Journal of Infection and ChemoTherapy 22(7): 444-449, 2017

Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. Critical Care Medicine 31(7): 1908-1914, 2003